First Tracks Biotherapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TRAX and other ETFs, options, and stocks.About TRAX
First Tracks Biotherapeutics, Inc. engages in the research and development of immunology therapeutics for autoimmune and inflammatory diseases. It focuses on clinical-stage programs for rosnilimab, ANB033 and ANB101.
TRAX Key Statistics
Stock Snapshot
First Tracks Biotherapeutics(TRAX) stock is priced at $17.01, giving the company a market capitalization of 595.26M.
First Tracks Biotherapeutics(TRAX) stock opened on 2026-06-30 at $16.25. The price climbed to — and dipped to —.
The First Tracks Biotherapeutics(TRAX)'s current trading volume is 0, compared to an average daily volume of 787.59K.
In the last year, First Tracks Biotherapeutics(TRAX) shares hit a 52-week high of $26.80 and a 52-week low of $14.72.
In the last year, First Tracks Biotherapeutics(TRAX) shares hit a 52-week high of $26.80 and a 52-week low of $14.72.
Analyst ratings
100%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.